Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Journal of Experimental Hematology ; (6): 1553-1558, 2018.
Article in Chinese | WPRIM | ID: wpr-689898

ABSTRACT

<p><b>OBJECTIVE</b>To study the coagulation properties the refrigerated whole blood stored at 4℃.</p><p><b>METHODS</b>Ten units of whole blood were obtained from healthy volunteer donors and stored at 4±2℃ for 21 days. Samples were collected on the day after donation and on days 2, 4, 6, 8, 10, 14 and 21 for delection including complete blood count, electrolyte, APTT, PT, Fg, blood coagulation factors, and thromboelastography(TEG).</p><p><b>RESULTS</b>The levels of Hb, WBC, Plt, sodium and potassium in each sample accorded with standard of storing whole blood. The level of Hb, WBC, Plt and Na decreased along with prolonging of storage time, while the K level increased along with prolonging of stored time, APTT and PT prolonged along with prolonging of thored time, PT>17 min at d 21, the Fg level change was no-obvious, The level of factor Ⅴ and Ⅷ decreased more than 50 % of baseline on d 6 and 4 respectively; the levels of factor Ⅱ, Ⅶ, Ⅸ, Ⅹ, Ⅺ, Ⅻ showed decreasing trend, but their levels were less than 40 % of baseline values at d 21. TEG test showed that no abnormalily of R value was found, the abnormal valnes of K and Angle were observed at d 21, the abnormal value of MA was observed at d 14.</p><p><b>CONCLUSION</b>The whole blood stored for 10 days possesses normal coagulation function showing important significance for treatment of hemorrhage from war injury and surgical openation of heart and chest.</p>

2.
Journal of Medical Postgraduates ; (12): 1177-1179, 2018.
Article in Chinese | WPRIM | ID: wpr-818005

ABSTRACT

ObjectiveCorrect identification of the blood type is an important prerequisite for ensuring the safety of clinical blood transfusion. This study was to explore the causes of blood type discrepancy of blood donors between preliminary screening and recheck and to propose some countermeasures for the reduction of errors.MethodsThis retrospective study included 114 398 cases of blood donation from 2009 to 2015. The blood types of the donors were preliminarily screened with the paper board and rechecked after blood collection. We investigated the causes and number of errors in preliminary blood type screening and analyzed the failure rates in the high-temperature months (July, August and September), low-temperature months (December, January and February), and moderate-temperature months (the other six months).ResultsPreliminary blood type screening errors occurred in 164 of the cases, 157 (95.73%) in blood group identification, mainly misidentification of type B antigen (43.95%) and type A antigen (23.5%). The rate of blood group identification errors was significantly higher in the high-temperature than in the low- and moderate-temperature months (0.19% vs 0.12% and 0.12%, P<0.05).ConclusionMisidentification of types B and A antigens and high-temperature environment are the main causes of the errors in preliminary blood type screening for blood donors.

3.
Journal of Experimental Hematology ; (6): 879-882, 2009.
Article in Chinese | WPRIM | ID: wpr-334004

ABSTRACT

The aim of the present study was to investigate the anti-proliferation and pro-apoptosis effect of Coix lachrymajobi L varma-yuan on acute T lymphoblast leukemia cell line Jurkat cells and its mechanism. Jurkat cells were treated with Coix lachrymajobi L varma-yuan of various concentrations (0, 0.4, 0.8, 1.6 mg/ml) for 24h. The inhibitory ratio was measured by Cell Counting Kit-8. The effects of Coix lachrymajobi L varma-yuan on apoptosis of Jurkat cells were determined by Hoechst 33258, PI and Annexin V-FITC/PI double staining. The mitochondrial membrane potential was analyzed by JC-1 staining. The results demonstrated that Coix lachrymajobi L varma-yuan inhibited the proliferation of Jurkat cells, and induced chromatin condensation and fragmentation (characteristic of apoptosis) and loss of mitochondrial membrane potential. In conclusion, Coix lachrymajobi L varma-yuan can inhibit the cell proliferation and induce the apoptosis of Jurkat cells. These effects relate to loss of mitochondrial membrane potential. These results suggest that Coix lachrymajobi L varma-yuan may be of value in treating lymphoma.


Subject(s)
Humans , Apoptosis , Cell Proliferation , Coix , Chemistry , Jurkat Cells , Membrane Potential, Mitochondrial , Plant Oils , Pharmacology
4.
Journal of Experimental Hematology ; (6): 922-925, 2008.
Article in Chinese | WPRIM | ID: wpr-267858

ABSTRACT

This study was purposed to investigate the effect of highway transportation on the quality of blood components so as to provide experimental basis to meet the needs of military operations. The transport condition was simulated by random vibration test. The red blood cells, leukocyte-reduced red blood cells, washed red blood cells were randomly vibrated (C Road) for 4 hours. Then, these blood components were stored in refrigerator for 15 days (4 degrees C). Six milliliters of blood were collected before vibration, after vibration, and at day 15 days of storage after vibration, respectively. The suspension was isolated. The free hemoglobin (FHb), routine hematological parameters, and biochemical indexes were determined. The results showed that FHb, lactate dehydrogenase (LDH), K(+) of red blood cells and leukocyte-reduced red blood cells did not significantly change after vibration and storage. However, FHb, LDH and K(+) of washed red blood cells increased significantly after simulated transportation (p < 0.05). The levels of these parameters at day 15 of storage after vibration were also significantly higher than those after vibration (p < 0.01). The changes of other hematological parameters were not significant in three blood components after vibration (C Road) and storage for 15 day. In conclusion, red blood cells and leukocyte-reduced red blood cells were qualified for clinic transfusion even after transportation within 4 hours for 15 day storage later, if they were kept in proper blood container and protected from damping. However, the washed red blood cells could not be used for clinic after similar transport in the military operations.


Subject(s)
Humans , Blood Preservation , Cryopreservation , Erythrocytes , Chemistry , L-Lactate Dehydrogenase , Blood , Transportation , Vibration
5.
Journal of Experimental Hematology ; (6): 506-509, 2008.
Article in Chinese | WPRIM | ID: wpr-253287

ABSTRACT

The aim of this study was to investigate the anti-proliferation and pro-apoptosis of triptolide on Jurkat cell line in acute T lymphocytic leukemia. The Jurkat cells were treated with various concentrations of triptolide (0, 1, 2, 4, 8, 16 microg/L) for 12 hours. The inhibitory ratio was measured by Cell Counting Kit-8 assay. The effects of triptolide on apoptosis of Jurkat cells were determined by DNA fragmentation (DNA ladder), Hoechst 33258, PI and Annexin V-FITC/PI double staining. The results demonstrated that triptolide inhibited the proliferation of Jurket cells. The 50% inhibitory concentration (IC(50)) was 4.0 microg/L. Chromatin condensation in the cells treated with triptolide could be seen by light microscopy. DNA electrophoresis showed evidence of nuclear fragmentation (DNA ladder). The hypoploid (sub-G(1)) population was increased after treatment with triptolide. The translocation of phosphatidylserine at the outer surface of the cell plasma membrane could be induced by triptolide. After treatment with triptolide for 12 hours, the rates of apoptotic cells were significantly increased. Moreover, these pro-apoptosis effects were in time-dependent manner. It is concluded that triptolide can inhibit the proliferation and induce the apoptosis of Jurkat cells. This study provides experimental basis for clinical use of triptolide in leukemia therapy.


Subject(s)
Humans , Antineoplastic Agents, Alkylating , Pharmacology , Apoptosis , Cell Proliferation , Diterpenes , Pharmacology , Epoxy Compounds , Pharmacology , Jurkat Cells , Phenanthrenes , Pharmacology
6.
Journal of Experimental Hematology ; (6): 1473-1476, 2008.
Article in Chinese | WPRIM | ID: wpr-234210

ABSTRACT

Endothelial progenitor cells are precursors of endothelial cells, which are able to differentiate into mature endothelial cells. Studies are needed to increase more detailed understanding on the mechanisms of EPC-differentiation, survival, homing and distribution of the tissue. The human EPC has potential to be used as diagnostic and prognostic or therapeutic tools in the future. This review describes recent studies on the biological characteristics and clinical application of EPC, including immunophenotype and functional characteristics of EPCs, mobilization, release and differentiation of EPCs, EPC number and recruitment, clinical application of EPCs, and so on.


Subject(s)
Humans , Endothelial Cells , Cell Biology , Stem Cells , Cell Biology
7.
Biomedical and Environmental Sciences ; (12): 470-477, 2007.
Article in English | WPRIM | ID: wpr-249823

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the therapeutic potential of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), a member of the TNF superfamily, and to analyze TRAIL-induced apoptosis in Jurkat cells.</p><p><b>METHODS</b>Expression of TRAIL receptors (DR4 and DR5) was detected by reverse transcriptase-polymerase chain reaction (RT-PCR). Cytotoxic effects were determined by colony formation assay and a cell counting kit. The effects of recombinant TRAIL on apoptosis of Jurkat cells were determined by DNA fragmentation (DNA ladder) and PI staining. Changes in mitochondrial membrane potential were detected with JC-1 fluorescence.</p><p><b>RESULTS</b>TRAIL inhibited the proliferation and induced internucleosomal DNA fragmentation (characteristic of apoptosis) and loss of mitochondrial membrane potential.</p><p><b>CONCLUSION</b>Recombinant soluble TRAIL can be used as a therapy for cancer.</p>


Subject(s)
Humans , Apoptosis , Base Sequence , DNA Primers , Electrophoresis, Agar Gel , Fluorescence , Jurkat Cells , Membrane Potentials , Recombinant Proteins , Pharmacology , Reverse Transcriptase Polymerase Chain Reaction , Solubility , TNF-Related Apoptosis-Inducing Ligand , Pharmacology
8.
National Journal of Andrology ; (12): 333-336, 2006.
Article in Chinese | WPRIM | ID: wpr-338299

ABSTRACT

<p><b>OBJECTIVE</b>To develop a nested polymerase chain reaction (PCR) technique for fetal SRY gene identification using cell-free fetal DNA in maternal plasma.</p><p><b>METHODS</b>Peripheral blood samples were obtained from 30 pregnant women and cell-free DNA was extracted by the phenol/chloroform method from plasma. The nested PCR was carried out to amplify the fragment of SRY gene by two sets of PCR primer pairs. Direct sequencing analysis was then performed on the PCR product.</p><p><b>RESULTS</b>Among the 17 women bearing male fetuses, SRY sequences were detected in 15 plasma samples after nested PCR amplification, while none of the 13 women bearing female fetuses had the positive results. The accuracy and sensitivity were 93.3% (28/30) and 88.2% (15/17), respectively.</p><p><b>CONCLUSION</b>The phenol/chloroform extraction for fetal DNA in maternal plasma was effective and simple. And the nested PCR amplification of SRY sequence is a convenient and low-cost approach for the non-invasive early prenatal diagnosis of sex-linked inheritant diseases.</p>


Subject(s)
Adult , Female , Humans , Pregnancy , Base Sequence , DNA , Blood , Genetics , Fetus , Genes, sry , Molecular Sequence Data , Polymerase Chain Reaction , Blood , Genetics , Prenatal Diagnosis , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL